Risankizumab
$4,475
Avg Cost per Claim
Brand Only
Medicare Part D spent $2345M on Skyrizi across 524,000 claims.
View full report →Source: CMS Medicare Part D Spending, 2026.
Data from DrugPrice
Medicare Part D spent $2345M on Skyrizi across 524,000 claims.
View full report →Source: CMS Medicare Part D Spending, 2026.